drugset
drugset / Trial / NCT02708004

Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects

NCT02708004 ↗

Phase 1 Completed 24 enrolled Idorsia Pharmaceuticals Ltd.
RandomizedCrossoverQuadruple-blindOther

Summary

This clinical study will be conducted to evaluate the effect of ACT-132577 on fluid homeostasis in healthy subjects.

Timeline

Start
2016-06-01
Primary completion
2016-12-01
Completion
2016-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprocitentan Small molecule — —

Indications

No indication recorded.